GENIUS SPORTS LTD (GENI)

GG00BMF1JR16 - Common Stock

5.19  +0.02 (+0.39%)

After market: 5.27 +0.08 (+1.54%)

Fundamental Rating

2

Overall GENI gets a fundamental rating of 2 out of 10. We evaluated GENI against 135 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of GENI is average, but there are quite some concerns on its profitability. While showing a medium growth rate, GENI is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

GENI had negative earnings in the past year.
GENI had a positive operating cash flow in the past year.

1.2 Ratios

GENI has a Return On Assets of -11.03%. This is amonst the worse of the industry: GENI underperforms 87.31% of its industry peers.
GENI has a Return On Equity of -14.93%. This is comparable to the rest of the industry: GENI outperforms 40.30% of its industry peers.
Industry RankSector Rank
ROA -11.03%
ROE -14.93%
ROIC N/A
ROA(3y)-34.2%
ROA(5y)N/A
ROE(3y)-43.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GENI's Gross Margin of 16.72% is on the low side compared to the rest of the industry. GENI is outperformed by 88.81% of its industry peers.
GENI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

GENI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GENI has more shares outstanding
Compared to 1 year ago, GENI has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.03 indicates that GENI is not a great score, but indicates only limited risk for bankruptcy at the moment.
GENI's Altman-Z score of 2.03 is in line compared to the rest of the industry. GENI outperforms 59.70% of its industry peers.
GENI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
GENI has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. GENI outperforms 93.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.03
ROIC/WACCN/A
WACC8.59%

2.3 Liquidity

GENI has a Current Ratio of 1.34. This is a normal value and indicates that GENI is financially healthy and should not expect problems in meeting its short term obligations.
GENI has a better Current ratio (1.34) than 66.42% of its industry peers.
A Quick Ratio of 1.34 indicates that GENI should not have too much problems paying its short term obligations.
The Quick ratio of GENI (1.34) is better than 70.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.11% over the past year.
Looking at the last year, GENI shows a very strong growth in Revenue. The Revenue has grown by 21.08%.
EPS 1Y (TTM)61.11%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q80.95%
Revenue 1Y (TTM)21.08%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q20.77%

3.2 Future

Based on estimates for the next years, GENI will show a very strong growth in Earnings Per Share. The EPS will grow by 36.18% on average per year.
GENI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.07% yearly.
EPS Next Y50.07%
EPS Next 2Y38.48%
EPS Next 3Y36.18%
EPS Next 5YN/A
Revenue Next Year16.74%
Revenue Next 2Y16.1%
Revenue Next 3Y16.07%
Revenue Next 5Y18.07%

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GENI. In the last year negative earnings were reported.
Also next year GENI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GENI is valued more expensive than 84.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 196.29

4.3 Compensation for Growth

A more expensive valuation may be justified as GENI's earnings are expected to grow with 36.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.48%
EPS Next 3Y36.18%

0

5. Dividend

5.1 Amount

GENI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GENIUS SPORTS LTD

NYSE:GENI (4/26/2024, 7:04:01 PM)

After market: 5.27 +0.08 (+1.54%)

5.19

+0.02 (+0.39%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.21B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.03%
ROE -14.93%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 16.72%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)61.11%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y50.07%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)21.08%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y